255 related articles for article (PubMed ID: 26569607)
21. Sialidase activity in human pathologies.
Glanz VY; Myasoedova VA; Grechko AV; Orekhov AN
Eur J Pharmacol; 2019 Jan; 842():345-350. PubMed ID: 30439363
[TBL] [Abstract][Full Text] [Related]
22. GPI-anchor signal sequence influences PrPC sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in mice.
Puig B; Altmeppen HC; Linsenmeier L; Chakroun K; Wegwitz F; Piontek UK; Tatzelt J; Bate C; Magnus T; Glatzel M
PLoS Pathog; 2019 Jan; 15(1):e1007520. PubMed ID: 30608982
[TBL] [Abstract][Full Text] [Related]
23. Post-conversion sialylation of prions in lymphoid tissues.
Srivastava S; Makarava N; Katorcha E; Savtchenko R; Brossmer R; Baskakov IV
Proc Natl Acad Sci U S A; 2015 Dec; 112(48):E6654-62. PubMed ID: 26627256
[TBL] [Abstract][Full Text] [Related]
24. Truncated forms of the human prion protein in normal brain and in prion diseases.
Chen SG; Teplow DB; Parchi P; Teller JK; Gambetti P; Autilio-Gambetti L
J Biol Chem; 1995 Aug; 270(32):19173-80. PubMed ID: 7642585
[TBL] [Abstract][Full Text] [Related]
25. Inhibitors of the Sialidase NEU3 as Potential Therapeutics for Fibrosis.
Karhadkar TR; Chen W; Pilling D; Gomer RH
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613682
[TBL] [Abstract][Full Text] [Related]
26. Structural basis for substrate specificity of mammalian neuraminidases.
Smutova V; Albohy A; Pan X; Korchagina E; Miyagi T; Bovin N; Cairo CW; Pshezhetsky AV
PLoS One; 2014; 9(9):e106320. PubMed ID: 25222608
[TBL] [Abstract][Full Text] [Related]
27. The extracellular sialidase NEU3 primes neutrophils.
Kirolos SA; Pilling D; Gomer RH
J Leukoc Biol; 2022 Dec; 112(6):1399-1411. PubMed ID: 35899930
[TBL] [Abstract][Full Text] [Related]
28. Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone.
Saborío GP; Soto C; Kascsak RJ; Levy E; Kascsak R; Harris DA; Frangione B
Biochem Biophys Res Commun; 1999 May; 258(2):470-5. PubMed ID: 10329411
[TBL] [Abstract][Full Text] [Related]
29. Identification of lysosomal sialidase NEU1 and plasma membrane sialidase NEU3 in human erythrocytes.
D'Avila F; Tringali C; Papini N; Anastasia L; Croci G; Massaccesi L; Monti E; Tettamanti G; Venerando B
J Cell Biochem; 2013 Jan; 114(1):204-11. PubMed ID: 22903576
[TBL] [Abstract][Full Text] [Related]
30. Existence of NEU1 sialidase on mouse thymocytes whose natural substrate is CD5.
Kijimoto-Ochiai S; Matsumoto-Mizuno T; Kamimura D; Murakami M; Kobayashi M; Matsuoka I; Ochiai H; Ishida H; Kiso M; Kamimura K; Koda T
Glycobiology; 2018 May; 28(5):306-317. PubMed ID: 29897583
[TBL] [Abstract][Full Text] [Related]
31. Sialidase NEU3 and its pathological significance.
Miyagi T; Yamamoto K
Glycoconj J; 2022 Oct; 39(5):677-683. PubMed ID: 35675020
[TBL] [Abstract][Full Text] [Related]
32. Analyses of N-linked glycans of PrP
Katorcha E; Baskakov IV
FEBS J; 2017 Nov; 284(21):3727-3738. PubMed ID: 28898525
[TBL] [Abstract][Full Text] [Related]
33. New insights on the sialidase protein family revealed by a phylogenetic analysis in metazoa.
Giacopuzzi E; Bresciani R; Schauer R; Monti E; Borsani G
PLoS One; 2012; 7(8):e44193. PubMed ID: 22952925
[TBL] [Abstract][Full Text] [Related]
34. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform.
Taraboulos A; Scott M; Semenov A; Avrahami D; Laszlo L; Prusiner SB
J Cell Biol; 1995 Apr; 129(1):121-32. PubMed ID: 7698979
[TBL] [Abstract][Full Text] [Related]
35. Neuraminidase 4 (NEU4): new biological and physiological player.
Okun S; Peek A; Igdoura SA
Glycobiology; 2023 Apr; 33(3):182-187. PubMed ID: 36728702
[TBL] [Abstract][Full Text] [Related]
36. Increased α-2,6 sialic acid on microglia in amyloid pathology is resistant to oseltamivir.
Fastenau C; Wickline JL; Smith S; Odfalk KF; Solano L; Bieniek KF; Hopp SC
Geroscience; 2023 Jun; 45(3):1539-1555. PubMed ID: 36867284
[TBL] [Abstract][Full Text] [Related]
37. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells.
Borchelt DR; Scott M; Taraboulos A; Stahl N; Prusiner SB
J Cell Biol; 1990 Mar; 110(3):743-52. PubMed ID: 1968466
[TBL] [Abstract][Full Text] [Related]
38. An optimized Western blot assay provides a comprehensive assessment of the physiological endoproteolytic processing of the prion protein.
Vanni I; Iacobone F; D'Agostino C; Giovannelli M; Pirisinu L; Altmeppen HC; Castilla J; Torres JM; Agrimi U; Nonno R
J Biol Chem; 2023 Feb; 299(2):102823. PubMed ID: 36565989
[TBL] [Abstract][Full Text] [Related]
39. Ageing and exposure to oxidative stress in vivo differentially affect cellular levels of PrP in mouse cerebral microvessels and brain parenchyma.
Williams WM; Stadtman ER; Moskovitz J
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):161-8. PubMed ID: 15043713
[TBL] [Abstract][Full Text] [Related]
40. Establishment and characterization of Prnp knockdown neuroblastoma cells using dual microRNA-mediated RNA interference.
Kang SG; Roh YM; Lau A; Westaway D; McKenzie D; Aiken J; Kim YS; Yoo HS
Prion; 2011; 5(2):93-102. PubMed ID: 21494092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
